These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24284475)

  • 1. Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
    Winstock AR; Kaar S; Borschmann R
    J Psychopharmacol; 2014 Jan; 28(1):49-54. PubMed ID: 24284475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
    McCambridge J; Winstock A; Hunt N; Mitcheson L
    Eur Addict Res; 2007; 13(1):57-64. PubMed ID: 17172780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile.
    Coney LD; Maier LJ; Ferris JA; Winstock AR; Barratt MJ
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28517366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT).
    Diab H; Malcolm B
    J Psychoactive Drugs; 2021; 53(2):140-145. PubMed ID: 33242285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).
    Cameron LP; Olson DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2344-2357. PubMed ID: 30036036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of classic psychedelics among adults: a Danish online survey study.
    Søgaard Juul T; Ebbesen Jensen M; Fink-Jensen A
    Nord J Psychiatry; 2023 May; 77(4):367-378. PubMed ID: 36173202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in DMT and other tryptamine use among young adults in the United States.
    Palamar JJ; Le A
    Am J Addict; 2018 Oct; 27(7):578-585. PubMed ID: 30260086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DMT at fifty.
    Szára S
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):201-5. PubMed ID: 18510265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.
    Falchi-Carvalho M; Wießner I; Silva SRB; O Maia L; Barros H; Laborde S; Arichelle F; Tullman S; Silva-Costa N; Assunção A; Almeida R; Pantrigo ÉJ; Bolcont R; Costa-Macedo JV; Arcoverde E; Galvão-Coelho N; Araujo DB; Palhano-Fontes F
    Eur Neuropsychopharmacol; 2024 Mar; 80():27-35. PubMed ID: 38141403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of recreational psychedelic substance use experiences classified by substance.
    Hase A; Erdmann M; Limbach V; Hasler G
    Psychopharmacology (Berl); 2022 Feb; 239(2):643-659. PubMed ID: 35031816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users.
    Cakic V; Potkonyak J; Marshall A
    Drug Alcohol Depend; 2010 Sep; 111(1-2):30-7. PubMed ID: 20570058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
    Griffiths RR; Hurwitz ES; Davis AK; Johnson MW; Jesse R
    PLoS One; 2019; 14(4):e0214377. PubMed ID: 31013281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence on LSD and other hallucinogenic drugs.
    JAMA; 1967 Oct; 202(1):141-4. PubMed ID: 6072003
    [No Abstract]   [Full Text] [Related]  

  • 16. The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.
    Videira NB; Nair V; Paquet V; Calhoun D
    J Appl Toxicol; 2024 Feb; 44(2):216-234. PubMed ID: 37646119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.
    Forstmann M; Kettner HS; Sagioglou C; Irvine A; Gandy S; Carhart-Harris RL; Luke D
    J Psychopharmacol; 2023 Jan; 37(1):93-106. PubMed ID: 36601974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
    Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between lifetime classic psychedelic use and markers of physical health.
    Simonsson O; Sexton JD; Hendricks PS
    J Psychopharmacol; 2021 Apr; 35(4):447-452. PubMed ID: 33719688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.